VBIT-4 or VBIT-12 activity in preventing apoptosis and disease-associated processes was demonstrated in several disease models where VDAC1 is overexpressed, such as in type-2-diabetes (T2D) [43], lupus [44], and colitis [45]. This evidence concerns the gene VDAC1 and systemic lupus erythematosus.